Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of the Royal College of Physicians of Edinburgh|April 13, 2016
Cranial ultrasound for the diagnosis of giant cell arteritis. A retrospective cohort studyA P Croft, N Thompson, M J Duddy, et al.Health Technology Assessment (Winchester, England)|April 15, 2008
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluationY-F Chen, P Jobanputra, P Barton, et al.Health Technology Assessment (Winchester, England)|October 20, 2006
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectivenessY-F Chen, P Jobanputra, P Barton, et al.Scandinavian Journal of Immunology|February 1, 1997
CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitroF R Brennan, K Mikecz, T T Glant, et al.Annals of the Rheumatic Diseases|August 1, 1992
Cellular immunity to cartilage proteoglycans: relevance to the pathogenesis of ankylosing spondylitisP Jobanputra, E H Choy, G H Kingsley, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 8, 1998
Hyperpolarisation of cultured human chondrocytes following cyclical pressure-induced strain: evidence of a role for alpha 5 beta 1 integrin as a chondrocyte mechanoreceptorM O Wright, K Nishida, C Bavington, et al.Health Technology Assessment (Winchester, England)|March 29, 2011
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluationK Malottki, P Barton, A Tsourapas, et al.Pageof 4